Dr. William Kevin Kelly's Guide To Standard & New Prostate Cancer Treatments
Dr. William Kevin Kelly, a medical oncologist at Thomas Jefferson University, explains how prostate cancer is treated and innovative new options.
Facing advanced prostate cancer can be a daunting process that brings out many questions and concerns, especially when it comes to understanding the treatment options, potential side effects, and how your life will be altered.
Here, Dr. W Kevin Kelly, the chair of medical oncology at Thomas Jefferson University’s Sidney Kimmel Comprehensive Cancer Center in Philadelphia, walks us through some of those options — from standard hormone therapy to innovative treatment advances and combinations.
Content independently created by SurvivorNet with support from Novartis Pharmaceuticals Corp.
Your Digital Guide begins below: 4 Chapters / 5 Video Segments
Dr. William Kevin Kelly
Thomas Jefferson University
For some patients who need to add a drug known as an ARPI to their treatment plan, darolutamibe has emerged as a top choice due to the potential for less side effects.
Dr. William Kevin Kelly
Thomas Jefferson University
For patients with prostate cancer, chemotherapy is sometimes offered in combination with other treatments, like surgery and hormone therapy, to increase their benefit and promote better outcomes.